Press release
microRNA (miRNA) Drug Market is expected to reach USD 4 billion by 2034, growing at a strong 10% CAGR
microRNA (miRNA) Drug Market
Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of miRNA Drug market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the miRNA Drug market.
This report is also available in the following languages : Japanese (miRNA薬), Korean (miRNA 약물), Chinese (miRNA药物), French (Médicament miRNA), German (miRNA-Medikament), and Italian (Farmaco miRNA), etc.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/66255
Key Companies:
Mirna Therapeutics , Regulus Therapeutics , Arrowhead Pharmaceuticals , Roche , Alnylam Pharmaceuticals , IONIS Pharmaceuticals , Moderna, Inc. , Silence Therapeutics , PTC Therapeutics , Sanofi , Novartis , Pfizer , Takeda Pharmaceutical Company , BioNTech , Thermo Fisher Scientific
Market Segmentation
By Product Type
Antisense Oligonucleotides
Agonists
By Application
Cancer
Cardiovascular Diseases
Neurological Disorders
By End User
Hospitals
Research Laboratories
Pharmaceutical Companies
By Technology
RNA Sequencing
PCR
Microarray
By Distribution Channel
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Explore Full Report here: https://exactitudeconsultancy.com/reports/66255/mirna-drug-market
If opting for the Global version of miRNA Drug Market; then the below country analysis would be included:
- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=66255
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the miRNA Drug market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the miRNA Drug market.
Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/66255
Reasons To Buy The miRNA Drug Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Our team is available 24/7 to assist and support our customers through reliable research.
Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.
Other Reports:
Restorative Artificial Teeth Market
https://exactitudeconsultancy.com/reports/65737/restorative-artificial-teeth-market
Intravascular Angiography Catheter Market
https://exactitudeconsultancy.com/reports/65757/intravascular-angiography-catheter-market
X-ray Protective Chair Market
https://exactitudeconsultancy.com/reports/65777/x-ray-protective-chair-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release microRNA (miRNA) Drug Market is expected to reach USD 4 billion by 2034, growing at a strong 10% CAGR here
News-ID: 4058842 • Views: …
More Releases from Exactitude Consultancy
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction
Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors.
Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,…
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction
Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics.
Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced…
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction
Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression.
Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate…
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
